Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 38, Issue 5, Pages 520-530
Publisher
Wiley
Online
2018-03-30
DOI
10.1002/phar.2108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of time horizon on results of cost-effectiveness analyses
- (2017) David D. Kim et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure
- (2017) Jacqueline Baras Shreibati et al. JACC-Heart Failure
- Cost-Effectiveness of Sacubitril–Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
- (2016) Alexander T. Sandhu et al. ANNALS OF INTERNAL MEDICINE
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
- (2016) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pay-for-performance pricing for a breakthrough heart drug: learnings for cell and gene therapies
- (2016) Nafees N Malik Regenerative Medicine
- Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction
- (2016) Marvin A. Konstam JACC-Heart Failure
- Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
- (2016) Jordan B. King et al. JACC-Heart Failure
- Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction
- (2016) Thomas A. Gaziano et al. JAMA Cardiology
- Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan
- (2015) Brian Claggett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure
- (2014) Elisa F. Long et al. Circulation-Heart Failure
- A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
- (2014) J. McMurray et al. EUROPEAN HEART JOURNAL
- A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure
- (2014) C McKenna et al. HEALTH TECHNOLOGY ASSESSMENT
- The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
- (2014) A Griffiths et al. HEART
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
- (2013) Clyde W. Yancy et al. CIRCULATION
- Epidemiology of Heart Failure
- (2013) Véronique L. Roger CIRCULATION RESEARCH
- Incremental Cost-Effectiveness of Guideline-Directed Medical Therapies for Heart Failure
- (2013) Gaurav Banka et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cost-effectiveness of heart failure therapies
- (2013) Luis E. Rohde et al. Nature Reviews Cardiology
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
- (2012) Stuart J. Pocock et al. EUROPEAN HEART JOURNAL
- Forecasting the Future of Cardiovascular Disease in the United States
- (2011) Paul A. Heidenreich et al. CIRCULATION
- Medication Adherence: WHO Cares?
- (2011) Marie T. Brown et al. MAYO CLINIC PROCEEDINGS
- Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers
- (2010) Zefeng Zhang et al. American Journal of Cardiovascular Drugs
- How Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?
- (2009) Milton C. Weinstein MEDICAL CARE
- Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
- (2009) George Miller et al. MEDICAL DECISION MAKING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started